x
Filter:
Filters applied
- JTO: Editors Choice
- SurgeryRemove Surgery filter
- August - November 2022Remove August - November 2022 filter
Editors Choice
2 Results
- Original Article Translational Oncology
Assessment of Updated Commission on Cancer Guidelines for Intraoperative Lymph Node Sampling in Early Stage NSCLC
Journal of Thoracic OncologyVol. 17Issue 11p1287–1296Published online: August 29, 2022- Brendan T. Heiden
- Daniel B. Eaton Jr.
- Su-Hsin Chang
- Yan Yan
- Martin W. Schoen
- Mayank R. Patel
- and others
Cited in Scopus: 2The American College of Surgeons Commission on Cancer recently updated its sampling recommendations for early stage NSCLC from at least 10 lymph nodes to at least one N1 (hilar) and three N2 (mediastinal) lymph node stations. Nevertheless, intraoperative lymph node sampling minimums remain subject to debate. We sought to evaluate these guidelines in patients with early stage NSCLC. - Review Article
Surgical, Radiation, and Systemic Treatments of Patients With Thymic Epithelial Tumors: A Clinical Practice Guideline
Journal of Thoracic OncologyVol. 17Issue 11p1258–1275Published online: August 28, 2022- Conrad B. Falkson
- Emily T. Vella
- Peter M. Ellis
- Donna E. Maziak
- Yee C. Ung
- Edward Yu
Cited in Scopus: 5The aim of this guideline was to provide recommendations for the most effective therapy for patients with thymic epithelial tumors, including thymoma, thymic carcinoma, and thymic neuroendocrine tumors (NETs). This guideline is intended to be used by all health care professionals managing patients with thymic epithelial tumors.